Teva Pharmaceuticals
TEVA
TEVA
537 hedge funds and large institutions have $11.9B invested in Teva Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 201 increasing their positions, 163 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 556 → 537 (-19)
12% less funds holding in top 10
Funds holding in top 10: 26 → 23 (-3)
19% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 69
Holders
537
Holding in Top 10
23
Calls
$589M
Puts
$312M
Top Buyers
| 1 | +$183M | |
| 2 | +$166M | |
| 3 | +$150M | |
| 4 |
SC
Soundwatch Capital
Rowayton,
Connecticut
|
+$138M |
| 5 |
PC
PointState Capital
New York
|
+$90.1M |
Top Sellers
| 1 | -$397M | |
| 2 | -$87.6M | |
| 3 | -$70.9M | |
| 4 |
Morgan Stanley
New York
|
-$70.7M |
| 5 |
Citigroup
New York
|
-$47.7M |